Abstract:A healthy 22-year-old man presented with a 1-month history of spontanaeous fingernail discolouration. The nails had changed from yellow to purplish-black in colour, associated with slight pain initially. Examination revealed distal onycholysis of all fingernails. Concave and ovoid areas of yellowish discolouration were present on the right and left second to fifth fingernails, respectively. The right second, third and fourth fingernails showed subungual haemorrhage, while splinter haemorrhages were evident on the left second, fourth and fifth fingernails (Figs 1,2). Toenails were unaffected. There was no rash elsewhere on his body. Presence of a soft parasternal systolic murmur prompted the referring physician to order a twodimensional echocardiogram on suspicion of an atrial myxoma or valvular defects causing peripheral emboli. This was normal. The patient later revealed that he had undergone 1 month of military training in Australia during the summer; during which he had taken oral doxycycline for treatment of facial acne. The nail changes occured a week after his return. A diagnosis of doxycycline-induced photo-onycholysis was made. The patient was expectantly managed. At follow up 3 months later, the nail changes had resolved. Onycholysis refers to the separation of the nail plate from the nail bed. Drug-induced photo-onycholysis occurs immediately after intake or several weeks after cessation of the offending drug. It may follow a photosensitivity reaction in the skin, or it can occur as the sole manifestation of a drug-induced phototoxic reaction, in the absence of cutaneous features. The convexity of the nail structure acting as a lens to focus ultraviolet radiation (UV) on the nail bed, the sparsity of melanin and absence of sebaceous glands in the nail bed are possible explanations for the predilection of photodamage in the nail. However, phototoxic changes may be demonstrated in clinically unaffected skin. In a patient who developed isolated onycholysis following doxycycline treatment, direct immunofluorescence of clinically normal sun-exposed skin revealed porphyrialike fluorescence with immunoglobulin M and immunoglobulin G deposition around papillary blood vessels. It is unclear whether UVA or UVB triggers the phototoxic reaction of drug-induced photo-onycholysis. Photosensitisation likely occurs only after prolonged and intense exposure to sunlight. Onychodynia, as our patient experienced, may precede onycholysis by 1 to 4 weeks and has been described only in association with tetracyclines and psoralen with UVA. The role of terminal vessels, capillaries or glomus bodies has been postulated, but the cause remains unknown. Local nail bed haemorrhage accounts for the dark red colour of the nails. Splinter haemorrhage occurrence has been reported in photo-onycholysis associated with Figure 1 Right fingernails showing yellowish distal onycholysis with superimposed haemorrhage.

The Effect of Different Meal Types on the Pharmacokinetics of Darunavir (TMC114)/Ritonavir in HIV‐Negative Healthy Volunteers

Effect of Food on the Pharmacokinetics of Tenofovir Amibufenamide: A Phase I, Randomized, Open-Label, Two-Period Crossover Trial in Healthy Adult Subjects

The natural history of idiopathic hypoglycemia of infancy and its relation to diabetes mellitus.

Pharmacokinetics of once-daily darunavir/ritonavir in second-line treatment in African children with HIV

Drug‐induced photo‐onycholysis: an often‐neglected phenomenon

Relative Bioavailability and Food Effect of GSK3640254 Tablet and Capsule Formulations in Healthy Participants

No effects of nirmatrelvir/ritonavir on darunavir plasma trough concentrations: a case report

Pharmacokinetics and safety of twice-daily ritonavir-boosted atazanavir with rifampicin.

Pharmacokinetics of Tenofovir Disoproxil Fumarate Tablets in Healthy Volunteers from Western China

Effects of meal type on the bioavailability of vutiglabridin, a novel anti‐obesity agent, in healthy subjects

Time Course of the Interaction Between Oral Short-Term Ritonavir Therapy with Three Factor Xa Inhibitors and the Activity of CYP2D6, CYP2C19, and CYP3A4 in Healthy Volunteers

A Phase 1 Study to Assess the Relative Bioavailability, Food Effect, and Safety of a Tablet Formulation of GSK2838232, a Novel HIV Maturation Inhibitor in Healthy Participants After Single and Repeated Doses

Type I Aneurysmosis: Complementary Index for Diagnosis

Clinical Pharmacodynamics, Pharmacokinetics, and Drug Interaction Profile of Doravirine

Synthetic mucin fragments. Benzyl O-beta-D-galactopyranosyl-(1----3)-O-(2-acetamido-2-deoxy-beta-D- glucopyranosyl)-(1----6)-2-acetamido-2-deoxy-alpha-D-galactopyranoside and O-alpha-L-fucopyranosyl-(1----3)-O-(2-acetamido-2-deoxy-beta-D- glucopyranosyl)-(1----6)-2-acetamido-2-deoxy-D-galactopyranos

Eff Ect of Quercetin on the Transport of Ritonavir to the Central Nervous System in Vitro and in Vivo

A phase IV, open-label three-arm study investigating the impact of a combination of tenofovir disoproxil fumarate/emtricitabine with raltegravir or dolutegravir or elvitegravir/cobicistat on renal function in HIV-1 antiretroviral naïve patients

Effect of Food on the Pharmacokinetics of Quizartinib

Pharmacokinetics of Atorvastatin and Metformin after Coadministration with Islatravir in Healthy Adults

Rapid clinical induction of hepatic cytochrome P4502B6 activity by ritonavir

Efficacy and safety of atazanavir/ritonavir-based antiretroviral therapy for HIV-1 infected subjects: a systematic review and meta-analysis